ImaginAb

ImaginAb's proprietary protein engineering technology enables a therapeutic antibody to be “fragmented” into a molecule that targets the same way as the therapeutic but clears the body rapidly and is able to be used with a radiolabel for imaging. ImaginAB's goal is to provide molecular imaging antibody fragments to aid in determining the extent of disease and choice of therapy for a given patient. ImaginAb initially focuses on ovarian and prostate cancer as an unmet need in molecular imaging diagnostics.

ImaginAb